Evasion and exploitation of chemokines by viruses

Cytokine and Growth Factor Reviews

Volumn 10, Issue 3-4, 1999, Pages 219-233

  Lalani, Alshad S ^a   McFadden, Grant ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Chemokine; Herpesvirus; Kaposi's sarcoma; Poxvirus; Viroceptor; Virokine

Indexed keywords

ALPHA CHEMOKINE; BINDING PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1; TRANSACTIVATOR PROTEIN; VIRAL CHEMOKINE CXC-1; VIRUS PROTEIN; VMIP-II;

ANIMAL; CHEMOTAXIS; GENETICS; HERPES VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PATHOGENICITY; POXVIRUS; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; CHEMOKINES; CHEMOKINES, CXC; HERPESVIRIDAE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; POXVIRIDAE; RECEPTORS, CHEMOKINE; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS; VIRUSES;

ANIMALIA; HERPES; HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; POXVIRIDAE;

EID: 0033192434     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00018-0     Document Type: Review

References (117)

1. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253.
2. Smith G.L. Virus strategies for evasion of the host response to infection. Trends Microbiol. 2:1994;81-88.
3. Gooding L.R. Virus proteins that counteract the immune system. Cell. 71:1992;5-7.
4. Spriggs M.K. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 14:1996;101-131.
5. Marrack P., Kappler J. Subversion of the immune system by pathogens. Cell. 76:1994;323-332.
6. McFadden G., Kane K. How DNA viruses perturb functional, MHC expression to alter immune recognition. Adv. Cancer Res. 63:1994;117-209.
7. McFadden G. DNA viruses that affect cytokine networks. Aggarwal B.B., Puri R.K. Human cytokines: their role in health and disease. 1994;403-422 Blackwell Press, Cambridge.
8. Barry M., McFadden G. Apoptosis regulators from DNA viruses. Curr. Opin. Immunol. 10:1998;422-430.
9. O'Brien V. Viruses and apoptosis. J. Gen. Virol. 79:1998;1833-1845.
10. Kotwal G.J. Microorganisms and their interaction with the immune system. J. Leuk. Biol. 62:1997;415-429.
11. Alcamí A., Symons J.A., Khanna A., Smith G.L. Poxviruses: Capturing cytokines and chemokines. Semin. Virol. 5:1998;419-427.
12. Barry M., McFadden G. Virus encoded cytokines and cytokine receptors. Parasitol. 115:1998;S89-S100.
13. McFadden G., Lalani A., Everett H., Nash P., Xu X. Virus encoded-receptors for cytokines and chemokines. Semin. Cell Dev. Biol. 9:1998;359-368.
14. McFadden G. Viroceptors, virokines and related immune modulators encoded by DNA viruses. 1995;R.G. Landes Company, Austin, TX.
15. Spriggs M.K. Poxvirus-encoded soluble cytokine receptors. Virus Res. 33:1994;1-10.
16. Smith G.L. Virus proteins that bind cytokines, chemokines or interferons. Curr. Opin. Immunol. 8:1996;467-471.
17. Smith G.L., Symons J.A., Alcamí A. Poxviruses: Interfering with interferon. Semin. Virol. 5:1998;409-418.
18. Luster A.D. Chemokines: Chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338:1998;436-445.
19. Baggiolini M., Dewald B., Moser B. Human chemokines: An update. Annu. Rev. Immunol. 15:1997;675-705.
20. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
21. Schall T.J. The chemokines. 1994;Academic Press, New York.
22. Locati M., Murphy P.M. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50:1999;425-440.
23. Schluger N.W., Rom W.N. Early responses to infection: Chemokines as mediators of inflammation. Curr. Opin. Immunol. 9:1997;504-508.
24. Cook D.N., Beck M.A., Coffman T.M., Kirby S.L., Sheridan J.F., Pragnell I.B., Smithies O. Requirement of MIP-1α for an inflammatory response to viral infection. Science. 269:1995;1583-1585.
25. Kinter A.L., Ostrowski M., Goletti D., Oliva A., Weissman D., Gantt K., Hardy E., Jackson R., Ehler L., Fauci A.S. HIV replication in CD4+ T-cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA. 93:1996;14076-14081.
26. + T cells. Science. 270:1995;1811-1815.
27. Mahalingham S., Farber J.M., Karupiah G. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73:1999;1479-1491.
28. Gallo R.C. The enigmas of Kaposi's sarcoma. Science. 282:1998;1837-1839.
29. Boshoff C., Weiss R.A. Kaposi's sarcoma-associated herpesvirus. Adv. Cancer Res. 75:1998;57-86.
30. Schulz T.F. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J. Gen. Virol. 79:1998;1573-1591.
31. Neipel F., Fleckenstein B. The role of HHV-8 in Kaposi's sarcoma. Sem. Cancer Biol. 9:1999;151-164.
32. Cesarman E., Knowles D.M. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Sem. Cancer Biol. 9:1999;165-174.
33. Sarid R., Olsen S.J., Moore P.S. Kaposi's sarcoma-associated herpesvirus: epidemiology, virology and molecular biology. Adv. Cancer Res. 52:1999;140-232.
34. Chatlynne L.G., Ablashi D.V. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin. Cancer Biol. 9:1999;175-185.
35. Ensoli B., Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cyt. Growth Fact. Rev. 9:1998;63-83.
36. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y.A., Moore P.S. Nucleotide sequence of the Kaposi Sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
37. Moore P.S., Boshoff C., Weiss R.A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 274:1996;1739-1744.
38. Nicholas J., Ruvolo V., Zong J.C., Ciufo D., Guo H.G., Reitz M.S., Hayward G.S. A single 13-kilobase divergent locus in the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71:1997;1963-1974.
39. Nicholas J., Ruvolo V.R., Burns W.H., Sandford G., Wan X., Ciufo D., Hendrickson S.B., Guo H.G., Hayward G.S., Reitz M.S. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Med. 3:1997;287-292.
40. Kledal T.N., Rosenkilde M.M., Coulin F., Simmons G., Johnsen A.H., Alouani S., Power C.A., Luttchau H.R., Gerstoft J., Clapham P.R., Clark-Lewis I., Wells T.N.C., Schwartz T.W. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science. 277:1997;1656-1659.
41. 3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J. Exp. Med. 188:1998;193-198.
42. Dairaghi D.J., Ran R.A., McMaster B.E., Hanley M.R., Schall T.J. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. J. Biol. Chem. 274:1999;21569-21574.
43. Endres M.J., Garlisi C.G., Xiao H., Shan L., Hedrick J.A. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J. Exp. Med. 189:1999;1993-1998.
44. O'Garra A., McEvoy L.M., Zlotnik A. T-cell subsets: chemokine receptors guide the way. Curr. Biol. 8:1998;646-649.
45. Sozzani S., Luini W., Bianchi G., Allavena P., Wells T.N., Naplitano M., Bernardini G., Vecchi A., D'Ambrosio D., Mazzeo D., Sinigaglia F., Santoni A., Maggi E., Romagnani S., Mantovani A. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood. 92:1998;4036-4039.
46. Boshoff C., Endo Y., Collins P.D., Takeuchi Y., Reeves J.D., Schweickart V.L., Siani M.A., Sasaki T., Williams T.J., Gray P.W., Moore P.S., Chang Y., Weiss R.A. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 278:1997;290-294.
47. Aoki Y., Jaffe E.S., Chang Y., Jones K., Teruya-Feldstein J., Moore P.S., Tosato G. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 93:1999;4034-4041.
48. Zou P., Isegawa Y., Nakano K., Haque M., Horiguchi Y., Yamanishi K. Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol. 73:1999;5926-5933.
49. Gompels U.A., Nicholas J., Lawrence G., Jones M., Thomson B.J., Martin M.E., Efstathiou S., Craxton M., Macaulay H.A. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution. Virology. 209:1995;29-51.
50. MacDonald M.R., Li X.-Y., Virgin I.V. H.W. Late expression of a β chemokine homolog by murine cytomegalovirus. J. Virol. 71:1997;1671-1678.
51. MacDonald M.R., Burney M.W., Resnick S.B., Virgin I.V. H.W. Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure. J. Virol. 73:1999;3682-3691.
52. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 1999;96:10881-6.
53. Fleming P., Davis-Poynter N., Esposti-Degli M., Densley E., Papadimitriou J., Shellam G., Farrell H. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J. Virol. 73:1999;6800-6809.
54. Penfold M.E.T., Dairaghi D.J., Duke G.M., Saederup N., Mocarski E.S., Kemble G.W., Schall T.J. Cytomegalovirus encodes a potent α chemokine. Proc. Natl. Acad. Sci. USA. 96:1999;9803-9808.
55. Birthistle K., Carrington D. Molluscum contagiosum virus. J. Infect. 34:1997;21-28.
56. Gottlieb S.L., Myskowski P.L. Molluscum contagiosum. Int. J. Dermatol. 33:1994;453-461.
57. Senkevich T.G., Bugert J.J., Sisler J.R., Koonin E.V., Darai G., Moss B. Genome sequence of a human tumorigenic poxvirus: Prediction of specific host response-evasion genes. Science. 273:1996;813-816.
58. Bugert J.J., Lohmuller C., Damon I., Moss B., Darai G. Chemokine homolog of molluscum contagiosum virus: sequence conservation and expression. Virology. 242:1998;51-59.
59. Krathwohl M.D., Hromas R., Brown D.R., Broxmeyer H.E., Fife K.H. Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proc. Natl. Acad. Sci. USA. 94:1997;9875-9880.
60. Damon I., Murphy P.M., Moss B. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc. Natl. Acad. Sci. USA. 95:1998;6403-6407.
61. LiWang A.C., Cao J.J., Zheng H., Lu Z., Peiper S.C., LiWang P.J. Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (vMIP-II) reveals a fully monomeric protein. Biochem. 38:1999;442-453.
62. 2-terminal residues. J. Exp. Med. 181:1995;631-640.
63. Wells T.N.C., Power C.A., Lusti-Narasimhan M., Hoogewerf A.J., Cooke R.M., Chung C., Peitsch M.C., Proudfoot A.E.I. Selectivity and antagonism of chemokine receptors. J. Leuk. Biol. 59:1996;53-60.
64. Moser B., Dewald B., Barella L., Schumacher C., Baggiolini M., Clark-Lewis I. Interleukin-8 antagonists generated by N-terminal modification. J. Biol. Chem. 268:1993;7125-7128.
65. Benelli R., Mortarini R., Anichini A., Giunciuglio D., Noonan D.M., Montalti S., Tacchetti C., Albini A. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides. AIDS. 12:1998;261-268.
66. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
67. Albini A., Benelli R., Giunciuglio D., Cai T., Mariana G., Ferrini S., Noonan D.M. Identification of a novel domain of HIV Tat involved in monocyte chemotaxis. J. Biol. Chem. 273:1998;15895-15900.
68. Albini A., Ferrini S., Benelli R., Sforzini S., Giunciuglio S., Aluigi S.G., Proudfoot A.E.I., Alouani S., Wells T.N.C., Mariani G., Rabin R.L., Farber J.M., Noonan D.M. HIV Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA. 95:1998;13153-13158.
69. Premack B.A., Schall T.J. Chemokine receptors: Gateways to inflammation and infection. Nature Med. 2:1996;1174-1178.
70. Zlotnik A., Morales J., Hedrick J.A. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 19:1999;1-47.
71. Murphy P.M. Chemokine receptors: Structure, function and role in microbial pathogenesis. Cyt. Growth Fact. Rev. 7:1996;47-64.
72. Taub D.D. Chemokine-leukocyte interactions: The voodoo that they do so well. Cyt. Growth Fact. Rev. 7:1996;355-376.
73. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
74. Littman D.R. Chemokine receptors: Keys to AIDS pathogenesis? Cell. 93:1998;677-680.
75. Chee M.S., Satchwell S.C., Preddie E., Weston K.M., Barrell B.G. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature. 344:1990;774-777.
76. Vieira J., Schall T.J., Corey L., Geballe A.P. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72:1998;8158-8165.
77. Gao J.L., Murphy P.M. Human cytomegalovirus open reading frame US28 encodes a functional β receptor. J. Biol. Chem. 269:1994;28539-28542.
78. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C-chemokine receptor. Cell. 72:1993;415-425.
79. Kledal T.N., Rosendike M.M., Schwartz T.W. Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett. 441:1998;209-214.
80. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seidedos F., Virelizier J.L., Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188:1998;855-866.
81. Pleskoff O., Treboute C., Brelot A., Heveker N., Seman M., Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science. 276:1997;1874-1878.
82. Davis-Poynter N.J., Lynch D.M., Vally H., Shellam G.R., Rawlinson W.D., Barrell B.G., Farrell H.E. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71:1997;1521-1529.
83. Margulies B.J., Browne H., Gibson W. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology. 225:1997;111-125.
84. Beisser P.S., Vink C., Van Dam J.G., Grauls G., Vanherle S.J., Bruggeman C.A. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J. Virol. 72:1998;2352-2363.
85. Isegawa Y., Ping Z., Nakano K., Sugimoto N., Yamanishi K. Human herpesvirus 6 open reading frame U12 encodes a functional β-chemokine receptor. J. Virol. 72:1998;6104-6112.
86. Nicholas J., Cameron K.R., Honess R.W. Herpesvirus saimiri encodes homologues of G-protein coupled receptors and cyclins. Nature. 355:1992;362-365.
87. Ahuja S.K., Murphy P.M. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J. Biol. Chem. 268:1993;20691-20694.
88. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 385:1997;347-349.
89. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., Asch A.S., Cesarman E., Gershengorn M.C., Mesri E.A. G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391:1998;86-89.
90. Burger M., Burger J.A., Hoch R.C., Oades Z., Takamori H., Schraufstatter I.U. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J. Immunol. 163:1999;2017-2022.
91. Rosenkilde M.M., Kledal T.N., Brauner-Osborne H., Schwartz T.W. Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J. Biol. Chem. 274:1999;956-961.
92. Geras-Raaka E., Varma A., Ho H., Clark-Lewis I., Gershengorn M.C. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Exp. Med. 188:1998;405-408.
93. Gershengorn M.C., Geras-Raaka E., Varma A., Clark-Lewis I. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J. Clin. Invest. 102:1998;1469-1472.
94. Kirshner J.R., Staskus K., Haase A., Lagunoff M., Ganem D. Expression of the open reading frame 74 (G protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J. Virol. 73:1999;6006-6014.
95. Telford E.A., Watson M.S., Aird H.C., Davison P.J. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249:1995;520-528.
96. Virgin H.W., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., Speck S.H. Complete sequence and genomic analysis of murine gamma-herpesvirus 68. J. Virol. 71:1997;5894-5904.
97. Sunil-Chandra N.P., Arno J., Fazakerley J., Nash A.A. Lymphoproliferative disease in mice infected with murine gamma-herpesvirus 68. Am. J. Pathol. 145:1994;818-826.
98. Virgin H.W., Speck S.H. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:1999;371-379.
99. Massung R.F., Jayarama V., Moyer R.W. DNA sequence analysis of conserved and unique regions of swinepox virus: Identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology. 197:1993;511-528.
100. Cao J.X., Gershon P.D., Black D.N. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G protein-coupled chemokine receptor homologue. Virology. 209:1995;207-212.
101. Lalani A.S., McFadden G. Secreted poxvirus chemokine binding proteins. J. Leuk. Biol. 62:1997;570-576.
102. Upton C., Mossman K., McFadden G. Encoding of a homolog of the interferon-γ receptor by myxoma virus. Science. 258:1992;1369-1372.
103. Mossman K., Upton C., McFadden G. The myxoma virus soluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species specific manner. J. Biol. Chem. 270:1995;3031-3038.
104. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 215:1996;17-30.
105. Lalani A.S., Graham K., Mossman K., Rajarathnam K., Clark-Lewis I., Kelvin D., McFadden G. The purified myxoma virus IFN-γ receptor homolog, M-T7, interacts with the heparin binding domains of chemokines. J. Virol. 71:1997;4356-4363.
106. Witt D.P., Lander A.D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:1994;394-400.
107. Clark-Lewis I., Kim K.S., Rajarathnam K., Gong J.H., Dewald B., Moser B., Baggiolini M., Sykes B.D. Structure-activity relationships of chemokines. J. Leuk. Biol. 57:1995;703-711.
108. McFadden G., Kelvin D. New strategies for chemokine inhibition and modulation: You take the high road and I'll take the low road. Biochem. Pharmacol. 54:1997;1271-1280.
109. Alcamí A., Symons J.A., Collins P.D., Williams T.J., Smith G.L. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:1998;624-633.
110. Jackson R.J., Hall D.F., Kerr P.J. Myxoma virus encodes an α2,3-sialyltransferase that enhances virulence. J. Virol. 73:1999;2376-2384.
111. Graham K.A., Lalani A.S., Macen J.L., Ness T.L., Barry M., Liu L.-Y., Lucas A., Clark-Lewis I., Moyer R.W., McFadden G. The T1/35 kDa family of poxvirus secreted proteins bind chemokines and modulate leukocyte influx into virus infected tissues. Virology. 229:1997;12-24.
112. Smith C.A., Smith T.D., Smolak P.J., Friend D., Hagen H., Gerhart M., Park L., Pickup D.J., Torrance D., Mohler K., Schooley K., Goodwin R.G. Poxvirus genomes encode a secreted soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 236:1997;316-327.
113. Lalani A.S., Ness T.L., Singh R., Harrison J.K., Seet B.T., Kelvin D.J., McFadden G., Moyer R.W. Functional comparisons among members of the poxvirus T1/35 kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology. 250:1998;173-184.
114. Lalani A.S., Masters J.M., Graham K.A., Liu L.Y., Lucas A., McFadden G. The role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology. 256:1999;233-245.
115. Martinez-Pomares L., Thompson J.P., Moyer R.W. Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox Virus. Virology. 206:1995;591-600.
116. Martin W.J. Melanoma growth stimulatory activity (MGSA/GRO-alpha) chemokine genes incorporated into an African green monkey simian cytomegalovirus-derived stealth virus. Exp. Mol. Pathol. 66:1999;15-18.
117. Peng Q., Zeng M., Bhuiyan Z.A., Ubukata E., Tanaka A., Nonoyama M., Shirazi Y. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology. 213:1995;590-599.